In some aggressive breast cancer subtypes, including TNBC and HER2-positive breast cancer, tumor-infiltrating lymphocytes play an important role in preventing tumor growth, which is important for both early-stage and advanced breast cancer. This evidence concerns the gene ERBB2 and neoplasm.